Mohamed-Reda Benmebarek

7PUBLICATIONS
55CO-AUTHORS
Haematological tumoursPeripheral nervous systemApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 07, 2025
SPP1 + macrophages cause exhaustion of tumor-specific T cells in liver metastases.

Rajiv Trehan, Patrick Huang, Xiao Bin Zhu

|Feb 08, 2024
The Gut Microbiome Controls Liver Tumors via the Vagus Nerve.

Kylynda C Bauer, Rajiv Trehan, Benjamin Ruf

|May 19, 2023
Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanoma.

Florian Märkl, Mohamed-Reda Benmebarek, Julius Keyl

|Jul 28, 2022
Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumors.

Sophia Stock, Mohamed-Reda Benmebarek, Anna-Kristina Kluever

|Jun 10, 2021
Combined tumor-directed recruitment and protection from immune suppression enable CAR T cell efficacy in solid tumors.

Bruno L Cadilha, Mohamed-Reda Benmebarek, Klara Dorman

|Jun 04, 2021
T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours.

Stefanie Lesch, Viktoria Blumenberg, Stefan Stoiber

Pageof 2

Frequent Collaborators

5 joint publications

Stefan Endres

5 joint publications

Sebastian Kobold

4 joint publications

Matthias Seifert

3 joint publications

Bruno L Cadilha